Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients

BACKGROUND: In HIV infected patients, the impact of ribavirin (RBV) pharmacology on sustained virologic response (SVR) to hepatitis C virus (HCV) treatment has not been fully investigated. The objective of this study was to compare the early RBV plasma exposure between a population of HIV-HCV coinfe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hatu, Giorgiana, Bailly, François, Pourcelot, Emmanuel, Pradat, Pierre, Miailhes, Patrick, Maynard, Marianne, Parant, François, Chiarello, Pierre, Livrozet, Jean-Michel, Zoulim, Fabien, Gagnieu, Marie-Claude
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2014
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3994577/
https://ncbi.nlm.nih.gov/pubmed/24650094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-150
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares